Changes in high-density lipoprotein cholesterol with risk of Cardiovascular Disease among initially high-density

Hye Jun Kim1, Seogsong Jeong2, Yun Hwan Oh3

  • 1Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea.

Insights

Increases in high-density lipoprotein cholesterol (HDL-C) may raise cardiovascular disease (CVD) risk in individuals with already high HDL-C levels. This association persists regardless of changes in low-density lipoprotein cholesterol (LDL-C).

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Public Health

Background:

  • High-density lipoprotein cholesterol (HDL-C) has been traditionally viewed as protective against cardiovascular disease (CVD).
  • Previous research often focused on mortality risk or single HDL-C measurements, potentially overlooking dynamic changes.
  • This study investigates the impact of HDL-C level fluctuations in individuals with elevated baseline HDL-C.

Purpose of the Study:

  • To examine the association between changes in HDL-C levels and the incidence of CVD.
  • To specifically analyze this relationship in a cohort with high baseline HDL-C (≥60 mg/dL).
  • To determine if HDL-C increases pose a risk irrespective of low-density lipoprotein cholesterol (LDL-C) changes.

Main Methods:

  • Utilized data from 77,134 participants in the Korea National Health Insurance Service-Health Screening Cohort.
  • Employed Cox proportional hazards regression to analyze the link between HDL-C change and incident CVD over 517,15 person-years.
  • Adjusted for numerous clinical and lifestyle factors, including age, BMI, diabetes, hypertension, smoking, and lipid profiles.

Main Results:

  • Individuals with the largest HDL-C increases showed significantly higher risks of CVD (aHR 1.15) and coronary heart disease (CHD) (aHR 1.27).
  • This elevated risk was observed compared to those with the smallest HDL-C increases.
  • The association between increased HDL-C and higher CHD risk remained significant even when low-density lipoprotein cholesterol (LDL-C) levels decreased (aHR 1.26).

Conclusions:

  • In individuals with high baseline HDL-C, further increases in HDL-C may paradoxically elevate CVD risk.
  • This potential risk increase is independent of changes in LDL-C levels.
  • The findings suggest that escalating HDL-C levels could unintentionally contribute to cardiovascular risk.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
27
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
211
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
616
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
39
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
882